AbbVie to Present at the Bank of America Securities Healthcare Conference

Rhea-AI Summary

AbbVie (NYSE: ABBV) will participate in the Bank of America Securities Healthcare Conference on May 13, 2026, with management appearing in a fireside chat at 1:20 p.m. Central Time. A live audio webcast will stream on AbbVie’s Investor Relations website, with an archive available later that day.

News Market Reaction – ABBV

-0.52%

-0.52% Session close to close

In the May 6 session, ABBV declined 0.52%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights AbbVie’s participation in a high-profile healthcare conference, with ma...

Analysis

This announcement highlights AbbVie’s participation in a high-profile healthcare conference, with management scheduled for a fireside chat at 1:20 p.m. Central Time on May 13, 2026. This type of event typically offers added visibility into strategy and portfolio priorities. Recent history shows the stock reacting more strongly to earnings, guidance changes, and major regulatory updates, so investors may watch for any incremental commentary that builds on those prior disclosures.

Key Figures

Conference fireside chat time: 1:20 p.m. Central Time

1 metrics

Conference fireside chat time 1:20 p.m. Central Time Scheduled time for AbbVie’s fireside chat at the conference on May 13, 2026

Historical Context

5 past events · Latest: May 05 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
May 05	IBD data presentations	Positive	-1.0%	Long-term real-world and clinical data for risankizumab and upadacitinib in IBD.
May 05	IBD trial update	Positive	-1.0%	Phase 1 and preclinical data for NIM-1324 showing target engagement and safety.
Apr 30	Philanthropic initiative	Positive	+3.6%	Allergan Aesthetics charitable campaign tied to new Allē member sign-ups.
Apr 29	Q1 2026 earnings	Positive	+3.1%	Q1 net revenue growth, key product strength, and raised 2026 EPS guidance.
Apr 28	Regulatory submission	Positive	+0.2%	FDA application for upadacitinib in severe alopecia areata based on Phase 3 data.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent ABBV news shows mostly positive fundamentals, with earnings and pipeline updates often met with gains, but some positive clinical and data presentations have coincided with mild downside moves.

Recent Company History

Over the past weeks, AbbVie reported strong Q1 2026 results on Apr 29, with higher revenues and raised EPS guidance, which coincided with gains of 3.14%. Regulatory progress for upadacitinib in alopecia areata on Apr 28 saw a modest 0.16% rise. Philanthropic initiatives via Allergan Aesthetics on Apr 30 aligned with a 3.64% gain. In contrast, positive IBD and NImmune Biopharma data presented on May 5 aligned with a -0.98% move, showing occasional divergence between upbeat data and price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NORTH CHICAGO, Ill., May 6, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Bank of America Securities Healthcare Conference on Wednesday, May 13, 2026. Management will participate in a fireside chat at 1:20 p.m. Central Time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.

Media: Gabby DioGuardi    (224) 244-0111 gabrielle.dioguardi@abbvie.com

Investors: Liz Shea (847) 935-2211 liz.shea@abbvie.com

 

View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-bank-of-america-securities-healthcare-conference-302763216.html

SOURCE AbbVie

FAQ

When will AbbVie (NYSE: ABBV) present at the Bank of America Securities Healthcare Conference?

AbbVie will present on May 13, 2026 at 1:20 p.m. Central Time. According to AbbVie, management will join a fireside chat and the session will be available live via audio webcast on the company's investor relations website, then archived later that day.

How can investors watch AbbVie’s (ABBV) presentation at the May 13, 2026 conference?

Investors can listen to a live audio webcast via AbbVie's Investor Relations website. According to AbbVie, the webcast will stream during the 1:20 p.m. Central Time fireside chat and an archived edition will be posted to the same site later the same day for on-demand access.

What time is AbbVie’s (ABBV) fireside chat at the Bank of America Healthcare Conference?

The fireside chat is scheduled for 1:20 p.m. Central Time on May 13, 2026. According to AbbVie, management will participate in that session and a live audio webcast will be accessible on the company's investor relations website, with an archive available later that day.

Will AbbVie (ABBV) provide an archived copy of its conference presentation?

Yes, an archived edition will be posted the same day as the live webcast. According to AbbVie, the audio webcast will be available live on the investor relations website and an archived version of the session will be accessible later on May 13, 2026 for on-demand listening.